日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

METTL3-mediated m(6)A modification of CACNA1E promotes osteosarcoma progression and chemoresistance by enhancing WNT7B-mediated Ca(2+) signaling.

METTL3 介导的 CACNA1E 的 m(6)A 修饰通过增强 WNT7B 介导的 Ca(2+) 信号传导促进骨肉瘤进展和化疗耐药性。

Chen Chaotao, Xiong Kai, Liang Feiyuan, Zhong Yanping, Qin Xiong, Huang Nanchang, Fang Yuqi, Zhu Bo, Cheng Jianwen, Wei Qingjun, Zheng Li, Zhao Jinmin

Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities.

表观遗传和转录程序决定骨肉瘤亚型并建立可靶向的脆弱性。

López-Fuentes Eunice, Clugston Andrew S, Lee Alex G, Sayles Leanne C, Sorensen Natalie, Pons Ventura Maria V, Leung Stanley G, Dinh Truc, Breese Marcus R, Sweet-Cordero E Alejandro

Corrigendum to "Mitochondria-targeted MXene@MnO(2)-TPP nanoheterostructures for synergistic enhancement of sonodynamic therapy and immunotherapy in osteosarcoma" [Bioact. Mat. 54 (2025) 450-465]

对“线粒体靶向 MXene@MnO(2)-TPP 纳米异质结构在骨肉瘤声动力疗法和免疫疗法中的协同增强作用”的更正 [Bioact. Mat. 54 (2025) 450-465]

Zeng, Jin; Yan, Zuyun; Wang, Dong; He, Tao; Tong, Zhaochen; Miao, Jinglei; Li, Jinsong; Tan, Wei; Chen, Shijie; Deng, Youwen

Manganese-potentiated cGAS-STING activation with ATM/PRMT5 inhibition remodels the immunosuppressive microenvironment in osteosarcoma via bone-targeted delivery

锰增强的cGAS-STING激活联合ATM/PRMT5抑制通过骨靶向递送重塑骨肉瘤中的免疫抑制微环境

Tong, Zhaochen; Li, Yuezhan; Zhang, Lingpu; Wen, Sijie; Wang, Dong; Li, Zixin; Peng, Yi; Wang, Weiguo; Miao, Jinglei; Xiao, Haihua; Xu, Dabao; Li, Jinsong; Chen, Shijie

Hydrogel delivering antifibrotic agent and nano-sonosensitizer enhances efficacy of sonodynamic therapy in osteosarcoma treatment.

递送抗纤维化剂和纳米声敏剂的水凝胶可增强声动力疗法在骨肉瘤治疗中的疗效。

Lin Shanyi, Liu Hao, Lv Letian, Jin Guanyu, Xiang Xinyu, Yu Bingzheng, Su Yuanzhen, Zhang Shucheng, Wang Zijuan, Yang Zhaofan, Wang Luyao, Liu Linlin, Lv Shixian, Guo Wei, Guo Yu

A polymeric triple-enzyme nanoparticle by light activatable crosslinking for cascade catalytic therapy of osteosarcoma.

利用光激活交联技术制备的聚合物三酶纳米颗粒用于骨肉瘤的级联催化治疗。

Ren Lanfang, Yu Xin, Yuan Chunyang, Zhu Fang, Zhou Haohan, Chen Qianqian, Lv Jia, Mei Zhoufang, Cheng Yiyun, Sun Zhengwang

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial

Olutasidenib治疗复发/再发性局部晚期或转移性IDH1突变软骨肉瘤:1b/2期试验

Jones, Robin L; Groisberg, Roman; Blay, Jean-Yves; Colman, Howard; De La Fuente, Macarena; Roxburgh, Patricia; Chao, Mwe Mwe; Tian, Hua; Duffaud, Florence; Bahleda, Rastislav; Van Tine, Brian A

ADAR2 induces the differentiation of osteosarcoma cells by editing activity on IGFBP7: new implications for therapy

ADAR2通过编辑IGFBP7诱导骨肉瘤细胞分化:对治疗的新启示

Rossi, Michela; Scotto di Carlo, Federica; Di Gregorio, Jacopo; Russo, Sharon; Di Giuseppe, Laura; Battafarano, Giulia; Terreri, Sara; Pagliarosi, Olivia; Silvestris, Domenico Alessandro; Corona, Marco; Barra, Adriano; Pezzullo, Marco; De Stefanis, Cristiano; Pelle, Simone; Costici, Pier Francesco; Minisola, Salvatore; Pepe, Jessica; Locatelli, Franco; Gianfrancesco, Fernando; Gallo, Angela; Del Fattore, Andrea

Correction to "LncDARS-AS1 Regulates ATP1A1 Stability and Enhances Na(+)/K(+) ATPase Activity to Promote Osteosarcoma Metastasis"

更正“LncDARS-AS1调节ATP1A1稳定性并增强Na(+)/K(+) ATPase活性以促进骨肉瘤转移”

HSP90AB1-Mediated Ubiquitin-Proteasome Degradation of ITGBL1 Promotes Osteosarcoma Progression by Inhibiting Endoplasmic Reticulum Stress-Induced Autophagy

HSP90AB1介导的ITGBL1泛素-蛋白酶体降解通过抑制内质网应激诱导的自噬促进骨肉瘤进展

Wang, Zhen; Guo, Zixuan; Cao, Chengwei; Wang, Ziying; Huang, Zifu; Zhang, Xiujuan; Zheng, Yushu; She, Diankun; Zhu, Hao; Yu, Lingfeng; Zhao, Xuelin; Xiang, Dongquan; Liao, Song; He, Xin; Ji, Xintong; Wu, Chengsheng; Xu, Cheng-Xiong; Xu, Meng